A Most Memorable Hockey Tribute Happened in Columbus Last Night
That Nate Silver Trendline Is Not Good News for Kamala
How Pelosi Responds When Asked If She Thought Biden Has Forgiven Her
Joe Biden Tried to Attack Trump. He Only Showed He's Mentally Cooked.
'Adios Michigan': Kamala Fails to Secure Another Key Endorsement
Harris' Town Hall Event With Charlamagne Got Roasted in the Comments
DeSantis Announces Update to Viral Video of Highway Patrol Rescuing Dog Abandoned as...
Georgia Judge Blocks Ballot Hand Counting Rule
Why This Average American Is Voting for Donald Trump…Again
Dems in Disarray: AOC and Fetterman Fighting Online Over Israel
Did You Notice Anything Odd at the Victoria's Secret Fashion Show?
Reality Again Debunks the Left's Ugly Lies and Misinformation About Georgia's Election Law
U.S. Army Training Materials Labeled Pro-Life Groups As Terrorists, Lawsuit Says
Catholic Group Doesn’t Buy Whitmer’s Apology for Stunt Mocking Catholics
Biden Administration Chooses Politics Over National Security and Norms
Tipsheet

Media Outlets Openly Report That the FDA's Latest Decision Was Political

The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill in the U.S.

In early 2024, Perrigo’s once-a-day Opill, a progestin-only pill, will be available at drug stores, supermarkets, and online.

Advertisement

“Today’s approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research, on Thursday. “When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy.”

There is no age restriction on the pill, despite concerns over correct usage and possible health hazards associated with it.

Seventeen advisers to the FDA voted unanimously in May to make Opill available over the counter despite concerns the agency raised about data Perrigo submitted with its application, including a study showing that many participants reported taking more pills than they were dispensed. The company said it couldn’t explain the discrepancy.

The agency questioned whether younger people and people with limited literacy could follow the dosing directions and said researchers likely used methods that exaggerated positive results. Perrigo said standards met or exceeded those used in other studies exploring over-the-counter drug adherence. (WSJ)

Kristan Hawkins of Students for Life said the news should mean pro-choice advocates won’t need abortions anymore, according to their own arguments. 

Advertisement

Others pointed out that media reports are not hiding the fact that it was a political decision. 

Health experts, citing the pill’s lengthy record of safety and effectiveness, have pushed for a nonprescription pill for years, but their campaign took on new urgency after the Supreme Court last year struck down the fundamental right to abortion established by Roe v. Wade. (WaPo)

Since the Supreme Court overturned the national right to an abortion last year, the accessibility of contraception has become an increasingly urgent issue. (NYT)

Though the drug itself and the campaign for its approval go back decades, pressure on the Biden administration to approve a hormonal over-the-counter birth control option increased after the fall of Roe v. Wade last year. (Politico)


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement